Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression.

Latham T, Mackay L, Sproul D, Karim M, Culley J, Harrison DJ, Hayward L, Langridge-Smith P, Gilbert N, Ramsahoye BH.

Nucleic Acids Res. 2012 Jun;40(11):4794-803. doi: 10.1093/nar/gks066. Epub 2012 Feb 9.

2.

p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.

Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM.

Oncol Rep. 2005 Jun;13(6):1139-44.

PMID:
15870934
3.

Inhibition of histone deacetylase activity by butyrate.

Davie JR.

J Nutr. 2003 Jul;133(7 Suppl):2485S-2493S. Review.

4.

Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver.

Lin T, Chen H, Koustova E, Sailhamer EA, Li Y, Shults C, Liu B, Rhee P, Kirkpatrick J, Alam HB.

Surgery. 2007 Jun;141(6):784-94.

PMID:
17560255
5.

Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells.

Taniura S, Kamitani H, Watanabe T, Eling TE.

J Biol Chem. 2002 May 10;277(19):16823-30. Epub 2002 Mar 4.

6.

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.

Marks PA, Richon VM, Rifkind RA.

J Natl Cancer Inst. 2000 Aug 2;92(15):1210-6. Review.

PMID:
10922406
7.

E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.

Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.

Oncogene. 2006 Jan 12;25(2):230-9.

PMID:
16158053
8.

Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.

Kang J, Chen J, Shi Y, Jia J, Zhang Y.

Biochem Pharmacol. 2005 Apr 15;69(8):1205-13.

PMID:
15794941
9.

Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.

Camarero N, Nadal A, Barrero MJ, Haro D, Marrero PF.

Nucleic Acids Res. 2003 Mar 15;31(6):1693-703.

10.
11.

microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.

Roccaro AM, Sacco A, Jia X, Azab AK, Maiso P, Ngo HT, Azab F, Runnels J, Quang P, Ghobrial IM.

Blood. 2010 Sep 2;116(9):1506-14. doi: 10.1182/blood-2010-01-265686. Epub 2010 Jun 2.

12.

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.

Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, Finn PW, Collins LS, Tumber A, Ritchie JW, Jensen PB, Lichenstein HS, Sehested M.

Biochem J. 2008 Jan 15;409(2):581-9.

PMID:
17868033
13.

Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts.

Yasukawa K, Sawamura D, Goto M, Nakamura H, Shimizu H.

Br J Dermatol. 2007 Oct;157(4):662-9. Epub 2007 Aug 17.

PMID:
17711521
14.

Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.

Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H, Lee HB.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F729-39. doi: 10.1152/ajprenal.00086.2009. Epub 2009 Jun 24.

15.

Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.

Bode KA, Schroder K, Hume DA, Ravasi T, Heeg K, Sweet MJ, Dalpke AH.

Immunology. 2007 Dec;122(4):596-606. Epub 2007 Jul 16.

16.
17.

Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation.

Naruse Y, Oh-hashi K, Iijima N, Naruse M, Yoshioka H, Tanaka M.

Mol Cell Biol. 2004 Jul;24(14):6278-87.

18.

Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis.

Koyama Y, Adachi M, Sekiya M, Takekawa M, Imai K.

Blood. 2000 Aug 15;96(4):1490-5.

20.

Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.

Algamas-Dimantov A, Yehuda-Shnaidman E, Peri I, Schwartz B.

Cell Oncol (Dordr). 2013 Apr;36(2):155-67. doi: 10.1007/s13402-012-0123-3. Epub 2013 Jan 11.

PMID:
23307400

Supplemental Content

Support Center